Effects of Garlic on Breast Tumor Cells with a Triple Negative Phenotype: Peculiar Subtype-Dependent Down-Modulation

Federica Brugnoli1, Marcello Dell'Aira1, Paola Tedeschi2

  • 1Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.

Cells
|May 24, 2024
PubMed

Insights

Garlic extract shows anti-tumoral effects on triple-negative breast cancer (TNBC) cells, but its impact varies by subtype. Further research into garlic

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Breast cancer exhibits significant heterogeneity, particularly triple-negative breast cancer (TNBC), complicating treatment outcomes.
  • Natural agents, like garlic (Allium sativum), are increasingly explored for their potential to complement conventional cancer therapies.
  • Garlic demonstrates anti-proliferative and anti-metastatic properties against various cancer cells.

Purpose of the Study:

  • To investigate the anti-tumoral activity of a garlic extract specifically in triple-negative breast cancer (TNBC) cell lines.
  • To explore how tumor heterogeneity influences the efficacy of garlic extract in TNBC.
  • To elucidate the molecular mechanisms underlying garlic's effects on TNBC.

Main Methods:

  • Utilized established triple-negative breast cancer (TNBC) cell lines derived from patient-derived xenografts (PDXs).
  • Evaluated the effects of garlic extract on cell morphology, cell cycle progression, and invasive potential.
  • Assessed the modulation of Akt signaling pathways in response to garlic treatment.

Main Results:

  • Garlic extract exhibited subtype-dependent effects on TNBC cell morphology, cell cycle, and invasiveness.
  • Observed a significant down-modulation of Akt signaling, a key regulator in tumor progression.
  • Demonstrated that the anti-tumoral effects of garlic are not uniform across all TNBC subtypes.

Conclusions:

  • Garlic extract possesses anti-tumoral activity against triple-negative breast cancer, but its efficacy is influenced by tumor heterogeneity.
  • The observed effects are partly mediated through the modulation of the Akt signaling pathway.
  • Personalized therapeutic strategies incorporating garlic require a deeper understanding of its specific mechanisms in distinct TNBC subtypes.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K